V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20029446 | 20012545 | 1.62 | 68.9 | Adjuvant (A) | 2014-01-06 | 2014-01-07 | FEC + DOCETAXEL | 2 | Y | 20103801 | FEC + DOCETAXEL |
| 20029447 | 20012545 | 1.72 | 73 | Adjuvant (A) | 2014-12-11 | 2014-12-18 | FEC + DOCETAXEL | 02 | N | 20103801 | FEC + DOCETAXEL |
| 20029448 | 20012546 | 1.49 | 79.4 | Neo-adjuvant (N) | 2013-08-07 | 2013-08-08 | FEC + DOCETAXEL | 02 | N | 20103807 | FEC + DOCETAXEL |
| 20029449 | 20012546 | 1.66 | 82 | Neo-adjuvant (N) | 2016-02-22 | 2016-02-25 | FEC + DOCETAXEL | 2 | N | 20103807 | FEC + DOCETAXEL |
| 20029450 | 20012546 | 1.61 | 54 | null | 2017-12-30 | 2018-01-06 | FEC + DOCETAXEL | 99 | N | 20103807 | FEC + DOCETAXEL |
| 20029451 | 20012546 | null | 93 | Adjuvant (A) | 2017-08-03 | 2017-08-09 | FEC + DOCETAXEL | 1 | N | 20103807 | FEC + DOCETAXEL |
| 20029452 | 20012546 | 1.65 | 74.4 | Adjuvant (A) | null | 2013-12-29 | FEC 100 + DOCETAXEL | N | N | 20103807 | FEC + DOCETAXEL |
| 20029453 | 20012546 | 1.68 | 67.6 | Curative (C) | 2013-08-18 | 2013-08-18 | FEC 100 + DOCETAXEL | 2 | N | 20103807 | FEC + DOCETAXEL |
| 20029454 | 20012546 | 1.67 | 69.4 | Adjuvant (A) | 2015-04-28 | 2015-04-28 | FEC + DOCETAXEL | 1 | N | 20103807 | FEC + DOCETAXEL |
| 20029455 | 20012546 | 1.86 | 67.8 | Adjuvant (A) | 2015-11-27 | 2015-11-27 | FEC + DOCETAXEL | 2 | N | 20103807 | FEC + DOCETAXEL |
| 20029456 | 20012547 | 1.56 | 61.5 | Adjuvant (A) | 2015-03-21 | 2015-03-22 | FEC 100 + DOCETAXEL | 02 | N | 20103849 | FEC + DOCETAXEL |
| 20029457 | 20012547 | 1.66 | 57 | Adjuvant (A) | 2013-07-01 | 2013-07-04 | FEC + DOCETAXEL | 02 | Y | 20103849 | FEC + DOCETAXEL |
| 20029458 | 20012548 | 1.7 | 75.5 | Adjuvant (A) | 2014-01-31 | 2014-02-15 | FEC + DOCETAXEL | 02 | N | 20103859 | FEC + DOCETAXEL |
| 20029459 | 20012549 | 1.62 | 100.4 | Not known (9) | 2017-01-18 | 2017-01-25 | FEC + DOCETAXEL | 02 | N | 20103860 | FEC + DOCETAXEL |
| 20029460 | 20012549 | 1.6 | 62 | Adjuvant (A) | 2015-08-15 | 2015-08-15 | FEC + DOCETAXEL | N | N | 20103860 | FEC + DOCETAXEL |
| 20029461 | 20012549 | 1.52 | 70.5 | Neo-adjuvant (N) | 2017-02-11 | 2017-02-12 | FEC + DOCETAXEL | 02 | N | 20103860 | FEC + DOCETAXEL |
| 20029462 | 20012550 | 1.7 | 71.8 | Adjuvant (A) | 2016-10-21 | 2016-10-23 | FEC + DOCETAXEL | 02 | N | 20103869 | FEC + DOCETAXEL |
| 20029463 | 20012550 | 1.54 | 79.8 | Adjuvant (A) | 2014-05-20 | 2014-06-03 | FEC + DOCETAXEL | 2 | null | 20103869 | FEC + DOCETAXEL |
| 20029464 | 20012551 | 1.68 | 68.4 | Not known (9) | null | 2015-10-18 | FEC + DOCETAXEL | N | N | 20103873 | FEC + DOCETAXEL |
| 20029465 | 20012552 | null | 119 | Curative (C) | 2017-01-18 | 2017-01-19 | FEC + DOCETAXEL | 02 | N | 20103878 | FEC + DOCETAXEL |
| 20029466 | 20012553 | 1.67 | 76 | Adjuvant (A) | 2013-06-11 | 2013-08-09 | FEC + DOCETAXEL | 99 | null | 20103879 | FEC + DOCETAXEL |
| 20029467 | 20012553 | 1.75 | 79.8 | Adjuvant (A) | 2018-03-26 | 2018-04-07 | FEC 100 + DOCETAXEL | N | N | 20103879 | FEC + DOCETAXEL |
| 20029468 | 20012553 | 1.64 | 75.3 | Neo-adjuvant (N) | 2013-12-24 | 2013-12-25 | FEC + DOCETAXEL | 02 | N | 20103879 | FEC + DOCETAXEL |
| 20029469 | 20012554 | 1.68 | 64 | Adjuvant (A) | 2016-01-08 | 2016-01-14 | FEC + DOCETAXEL | 02 | N | 20103887 | FEC + DOCETAXEL |
| 20029470 | 20012554 | 1.61 | 65.42 | Adjuvant (A) | 2016-10-09 | 2016-10-16 | FEC + DOCETAXEL | 02 | N | 20103887 | FEC + DOCETAXEL |
| 20029471 | 20012554 | null | 74.2 | Neo-adjuvant (N) | 2017-10-16 | 2017-11-10 | FEC + DOCETAXEL | Y | null | 20103887 | FEC + DOCETAXEL |
| 20029472 | 20012554 | 1.59 | 75 | Adjuvant (A) | 2017-08-19 | 2017-08-19 | FEC + DOCETAXEL | 2 | N | 20103887 | FEC + DOCETAXEL |
| 20029473 | 20012554 | 1.58 | 81 | Neo-adjuvant (N) | 2015-09-25 | 2015-09-25 | FEC + DOCETAXEL | 02 | N | 20103887 | FEC + DOCETAXEL |
| 20029474 | 20143148 | null | null | Adjuvant (A) | null | 2015-04-14 | FEC + DOCETAXEL | null | null | 20103895 | FEC + DOCETAXEL |
| 20029475 | 20143148 | 1.57 | 61 | Adjuvant (A) | 2014-11-18 | 2014-12-10 | FEC 100 + DOCETAXEL | null | null | 20103895 | FEC + DOCETAXEL |
| 20029476 | 20012555 | 1.72 | 75.4 | Adjuvant (A) | null | 2015-05-08 | FEC 100 + DOCETAXEL | N | N | 20103909 | FEC + DOCETAXEL |
| 20029477 | 20012556 | 1.58 | 86 | Neo-adjuvant (N) | 2013-02-08 | 2013-02-08 | FEC + DOCETAXEL | 02 | N | 20103913 | FEC + DOCETAXEL |
| 20029478 | 20072555 | 1.58 | 63.8 | Adjuvant (A) | 2015-11-06 | 2015-11-07 | FEC + DOCETAXEL | 02 | N | 20103915 | FEC + DOCETAXEL |
| 20029479 | 20072555 | 1.59 | null | null | 2015-04-02 | 2015-04-22 | FEC 100 + DOCETAXEL | N | N | 20103915 | FEC + DOCETAXEL |
| 20029480 | 20012557 | 1.62 | 125 | Adjuvant (A) | 2017-03-19 | 2017-04-02 | FEC + DOCETAXEL | 02 | N | 20103917 | FEC + DOCETAXEL |
| 20029481 | 20012557 | 1.7 | 66.6 | Curative (C) | 2016-05-30 | 2016-06-06 | FEC + DOCETAXEL | 02 | N | 20103917 | FEC + DOCETAXEL |
| 20029482 | 20012558 | 1.66 | 87 | Not known (9) | 2013-03-03 | 2013-03-19 | FEC 100 + DOCETAXEL | 02 | null | 20103922 | FEC + DOCETAXEL |
| 20029483 | 20012559 | 1.62 | 94 | Adjuvant (A) | 2016-05-25 | 2016-06-13 | FEC + DOCETAXEL | 02 | N | 20103923 | FEC + DOCETAXEL |
| 20029484 | 20012559 | 1.65 | 80.8 | Adjuvant (A) | 2016-10-08 | 2016-10-19 | FEC + DOCETAXEL | 02 | N | 20103923 | FEC + DOCETAXEL |
| 20029485 | 20012560 | 1.52 | 71.8 | Adjuvant (A) | 2015-07-10 | 2015-07-10 | FEC + DOCETAXEL | 02 | N | 20103926 | FEC + DOCETAXEL |
| 20029486 | 20012560 | 1.73 | 89 | Adjuvant (A) | 2016-05-05 | 2016-05-19 | FEC 100 + DOCETAXEL | 2 | N | 20103926 | FEC + DOCETAXEL |
| 20029487 | 20012560 | 1.58 | 90.85 | Disease modification (D) | 2015-10-28 | 2015-10-28 | FEC 100 + DOCETAXEL | 02 | N | 20103926 | FEC + DOCETAXEL |
| 20029488 | 20012561 | null | null | Adjuvant (A) | null | 2014-07-30 | FEC + DOCETAXEL | null | null | 20103935 | FEC + DOCETAXEL |
| 20029489 | 20012561 | 1.57 | 58.6 | Neo-adjuvant (N) | 2015-12-14 | 2015-12-14 | FEC 100 + DOCETAXEL | 02 | null | 20103935 | FEC + DOCETAXEL |
| 20029490 | 20012562 | 1.69 | 173 | Adjuvant (A) | 2017-01-22 | 2017-02-12 | FEC 100 + DOCETAXEL | 02 | N | 20103939 | FEC + DOCETAXEL |
| 20029491 | 20012563 | 1.68 | 100.7 | Adjuvant (A) | null | 2013-10-28 | FEC + DOCETAXEL | null | N | 20103940 | FEC + DOCETAXEL |
| 20029492 | 20012563 | 1.75 | null | Neo-adjuvant (N) | 2016-07-16 | 2016-07-22 | FEC + DOCETAXEL | N | N | 20103940 | FEC + DOCETAXEL |
| 20029493 | 20012563 | 1.65 | 71 | Adjuvant (A) | 2014-12-25 | 2015-01-16 | FEC + DOCETAXEL | N | N | 20103940 | FEC + DOCETAXEL |
| 20029494 | 20012564 | null | null | Palliative (P) | 2014-03-22 | 2014-05-19 | FEC + DOCETAXEL | 99 | null | 20103945 | FEC + DOCETAXEL |
| 20029495 | 20012564 | 1.73 | 57.8 | Neo-adjuvant (N) | null | 2016-10-21 | FEC 100 + DOCETAXEL | N | N | 20103945 | FEC + DOCETAXEL |